Evidence map›Paper›PMID 27824079›Full record

ArticleScientific reports2016

Mena

Maxwell D Weidmann, Chinmay R Surve, Robert J Eddy, Xiaoming Chen, Frank B Gertler, Ved P Sharma, John S Condeelis

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03694756 (TMEM-MRI), which is not on this map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03694756 narecruitingnot on this mapstarted 2018, after this paper: background citation

TMEM-MRI: A Pilot Feasibility Study of Magnetic Resonance Imaging for Imaging of TMEM (Tumor Microenvironment of Metastasis) in Patients With Operable Breast Cancer

TypeinterventionalSponsorMontefiore Medical CenterRan2018 to 2026Enrolled95ConditionsBreast CancerArmsTMEM-MRI, FNA
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Maxwell D WeidmannDepartment of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, NY, USA.
Chinmay R SurveDepartment of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, NY, USA.
Robert J EddyDepartment of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, NY, USA.
Xiaoming ChenDepartment of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, NY, USA.
Frank B GertlerDepartment of Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Ved P SharmaDepartment of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, NY, USA.
John S CondeelisDepartment of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, NY, USA.
Albert Einstein College of Medicine · USMassachusetts Institute of Technology · US

Funding

Tumor Progression and MetastasisP01CA100324 · NCI · YESHIVA UNIVERSITY · PI CONDEELIS, JOHN S · 2003 to 2018
$30.0M
Signal transduction regulating tumor cell disseminationR01CA150344 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CONDEELIS, JOHN S · 2010 to 2020
$3.7M
NCI NIH HHS P01 CA100324NCI NIH HHS R01 CA150344
6 · The paper itself

Abstract

Invadopodia, actin-based protrusions of invasive carcinoma cells that focally activate extracellular matrix-degrading proteases, are essential for the migration and intravasation of tumor cells during dissemination from the primary tumor. We have previously shown that cortactin phosphorylation at tyrosine residues, in particular tyrosine 421, promotes actin polymerization at newly-forming invadopodia, promoting their maturation to matrix-degrading structures. However, the mechanism by which cells regulate the cortactin tyrosine phosphorylation-dephosphorylation cycle at invadopodia is unknown. Mena, an actin barbed-end capping protein antagonist, is expressed as various splice-isoforms. The Mena

Indexed as

Cell MovementAnimalsBreast NeoplasmsCell Line, TumorCortactinFemaleHumansMiceMicrofilament ProteinsNeoplasm InvasivenessNeoplasm ProteinsPhosphorylationPodosomesProtein IsoformsProtein Tyrosine Phosphatase, Non-Receptor Type 1CortactinCTTN protein, humanEnah protein, humanMicrofilament ProteinsNeoplasm ProteinsProtein IsoformsProtein Tyrosine Phosphatase, Non-Receptor Type 1PTPN1 protein, human

Identifiers

PMID27824079
PMCPMC5099927
OpenAlexW2550377271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.